Here, we found that 2‐DG could reverse the chemoresistance, which indicated that 2‐DG could sensitize INSL5 highly expressed NPC to chemotherapy (Figs 6F and EV5C). Here, INSL5 is linked to nasopharyngeal carcinoma.